Disruption of frontal theta coherence by δ 9-tetrahydrocannabinol is associated with positive psychotic symptoms

Neuropsychopharmacology

Volumn 36, Issue 4, 2011, Pages 827-836

  Morrison, Paul D ^a   Nottage, Judith ^a   Stone, James M ^a,b   Bhattacharyya, Sagnik ^a   Tunstall, Nigel ^a   Brenneisen, Rudolf ^c   Holt, David ^d   Wilson, Daniel ^a,e   Sumich, Alex ^a,e   McGuire, Philip ^a   Murray, Robin M ^a   Kapur, Shitij ^a   Ffytche, Dominic H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

9 tetrahydrocannabinol; EEG; psychosis; theta

Indexed keywords

CANNABIS; DRONABINOL; PLACEBO;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAPHY; FEMALE; FOURIER TRANSFORMATION; FRONTAL LOBE; HUMAN; MALE; NEGATIVE SYNDROME; NEUROPHYSIOLOGY; POSITIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SCHIZOPHRENIA; THETA RHYTHM; VOLUNTEER; WORKING MEMORY;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NERVE NET; PSYCHOSES, SUBSTANCE-INDUCED; TETRAHYDROCANNABINOL; THETA RHYTHM; YOUNG ADULT;

EID: 79951515596     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.222     Document Type: Article

References (48)

1. Arseneault L, Cannon M, Witton J, Murray RM (2004). Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-117. (Pubitemid 38186851)
2. Bocker KB, Hunault CC, Gerritsen J, Kruidenier M, Mensinga TT, Kenemans JL (2010). Cannabinoid modulations of resting state EEG theta power and working memory are correlated in humans. J Cogn Neurosci 22: 1906-1916.
3. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N et al (2005). Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25: 6845-6856. (Pubitemid 41023152)
4. Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T et al (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35: 764-774.
5. Buzsaki G (2006). Rhythms of The Brain. Oxford University Press: New York.
6. Buzsaki G, Draguhn A (2004). Neuronal oscillations in cortical networks. Science 304: 1926-1929.
7. Canolty RT, Edwards E, Dalal SS, Soltani M, Nagarajan SS, Kirsch HE et al (2006). High gamma power is phase-locked to theta oscillations in human neocortex. Science 313: 1626-1628. (Pubitemid 44414034)
8. Chevaleyre V, Takahashi KA, Castillo PE (2006). Endocannabi-noid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76.
9. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G et al (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57: 594-608. (Pubitemid 40409699)
10. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558-1572. (Pubitemid 38982249)
11. Eggan SM, Lewis DA (2007). Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17: 175-191. (Pubitemid 44973906)
12. Eggan SM, Melchitzky DS, Sesack SR, Fish KN, Lewis DA (2010). Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience 169: 1651-1661.
13. Ford JM, Mathalon DH (2008). Neural synchrony in schizophrenia. Schizophr Bull 34: 904-906.
14. Ford JM, Mathalon DH, Whitfield S, Faustman WO, Roth WT (2002). Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry 21: 485-492. (Pubitemid 34260970)
15. Freund TF, Katona I, Piomelli D (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066. (Pubitemid 36828930)
16. Glass M, Dragunow M, Faull RL (1997). Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77: 299-318. (Pubitemid 27079604)
17. Goldberg DP, Blackwell B (1970). Psychiatric illness in general practice. A detailed study using a new method of case identification. BMJ 1: 439-443.
18. Haenschel C, Bittner RA, Waltz J, Haertling F, Wibral M, Singer W et al (2009). Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci 29: 9481-9489.
19. Hajos M, Hoffmann WE, Kocsis B (2008). Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63: 1075-1083.
20. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991). Characterization and localization of cannabi-noid receptors in rat brain: a quantitative in vitro autoradio-graphic study. J Neurosci 11: 563-583.
21. Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P et al (2007). Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neuro-physiol 97: 2580-2589. (Pubitemid 46557693)
22. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al (2002). International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202. (Pubitemid 34575709)
23. Huerta PT, Lisman JE (1993). Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 364: 723-725. (Pubitemid 23273126)
24. Ilan AB, Smith ME, Gevins A (2004). Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl) 176: 214-222. (Pubitemid 39517951)
25. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276. (Pubitemid 18039085)
26. Kopell N, Ermentrout GB, Whittington MA, Traub RD (2000). Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci USA 97: 1867-1872. (Pubitemid 30118535)
27. Kuepper R, Morrison PD, van Os J, Murray RM, Kenis G, Henquet C (2010). Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res 121: 107-117.
28. Mechoulam R, Shani A, Edery H, Grunfeld Y (1970). Chemical basis of hashish activity. Science 169: 611-612.
29. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328. (Pubitemid 47094993)
30. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF et al (2009). The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 39: 1607-1616.
31. Murray RM, Morrison PD, Henquet C, Di Forti M (2007). Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8: 885-895. (Pubitemid 350006219)
32. Naef M, Russmann S, Petersen-Felix S, Brenneisen R (2004). Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans. J Pharm Sci 93: 1176-1184. (Pubitemid 38529691)
33. Nottage JF (2010). Uncovering gamma in visual tasks. Brain Topogr 23: 58-71.
34. Owen AM, McMillan KM, Laird AR, Bullmore E (2005). N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25: 46-59. (Pubitemid 40656192)
35. Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153: 199-215.
36. Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884. (Pubitemid 37351427)
37. Ranganathan M, D'Souza DC (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharma-cology (Berl) 188: 425-444. (Pubitemid 44498214)
38. Robbe D, Montgomery SM, Thome A, Rueda-Orozco PE, McNaughton BL, Buzsaki G (2006). Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 9: 1526-1533. (Pubitemid 44862661)
39. Rodriguez E, George N, Lachaux JP, Martinerie J, Renault B, Varela FJ (1999). Perception's shadow: long-distance synchronization of human brain activity. Nature 397: 430-433.
40. Sarnthein J, Petsche H, Rappelsberger P, Shaw GL, von Stein A (1998). Synchronization between prefrontal and posterior association cortex during human working memory. Proc Natl Acad Sci USA 95: 7092-7096. (Pubitemid 28278112)
41. Schmiedt C, Brand A, Hildebrandt H, Basar-Eroglu C (2005). Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controls. Brain Res Cogn Brain Res 25: 936-947. (Pubitemid 41774456)
42. Sewell RA, Ranganathan M, D'Souza DC (2009). Cannabinoids and psychosis. Int Rev Psychiatry 21: 152-162.
43. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA (2010). Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464: 763-767.
44. Stephan KE, Friston KJ, Frith CD (2009). Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 35: 509-527.
45. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W (2008). The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 34: 927-943.
46. Uhlhaas PJ, Pipa G, Lima B, Melloni L, Neuenschwander S, Nikolic D et al (2009). Neural synchrony in cortical networks: history, concept and current status. Front Integr Neurosci 3: 17.
47. Uhlhaas PJ, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11: 100-113.
48. Varela F, Lachaux JP, Rodriguez E, Martinerie J (2001). The brainweb: phase synchronization and large-scale integration. Nat Rev Neurosci 2: 229-239. (Pubitemid 33673064)